Click on a filter below to refine your search. Remove a filter to broaden your search.
One-third of those say their lives were disrupted by the overdose death.
Nurse practitioners were overrepresented among clinicians with the highest and lowest rates of inappropriate prescribing.
Significant reductions were seen in dementia risk for rivaroxaban, apixaban and dabigatran versus warfarin in a network meta-analysis.
Dapagliflozin, however, does not reduce the urinary albumin-to-creatinine ratio in those patients.
Lixisenatide results in less progression of motor disability than placebo at 12 months for individuals with early Parkinson’s disease.
The GA enlargement rate in the study eyes did not differ significantly in the run-in and treatment phases in age-related macular degeneration.
Baseline CRP, Clinical Disease Activity Index and glucocorticoid dose predict resistance to CDAI-low disease activity achievement.
Changes in office systolic BP of −14.1, −13.2, −6.9 and −4.1 mm Hg were seen with 100, 50, 12.5 mg once daily of lorundrostat and placebo.
A Phase 3 trial showed noninferiority versus lansoprazole in healing and maintenance phases.
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.